Please assess the completion status of the following clinical trial:

Trial Title: China Micra Transcatheter Pacing Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Subjects who have a Class I or II indication for implantation of a single chamber ventricular pacemaker according to ACC/AHA/HRS 2008 guidelines and China guideline.~2. Subjects who are willing to participate in study through consent and willing to undergo study specific required procedures with expectancy of geographically stable for follow up duration.~3. Subjects who are at least 18 years of age.~Exclusion Criteria:~1. Subject has an existing or prior pacemaker, ICD or CRT device implant.~2. Subject has unstable angina pectoris or has had an acute myocardial infarction (AMI) in the 30 days prior to eligibility assessment.~3. Subjects with current implantation of neurostimulator or any other chronically implanted device which uses current in the body. Note that a temporary pacing wire is allowed.~4. Subjects with a mechanical tricuspid valve, implanted vena cava filter, or left ventricular assist device (LVAD).~5. Subjects who are morbidly obese and physician believes telemetry communication of ≤5 inches (12.5 cm) could not be obtained with programmer head.~6. Subjects whose femoral venous anatomy is unable to accommodate a 23 French introducer sheath or implant on the right side of the heart (for example, due to obstructions or severe tortuosity) in the opinion of the implanter.~7. Subjects who are considered as unable to tolerate an urgent sternotomy.~8. Subjects with a known intolerance to Nickel-Titanium (Nitinol) Alloy.~9. Subjects for whom a single dose of 1.0mg dexamethasone acetate may be contraindicated.~10. Subjects with a life expectancy of less than 12-months.~11. Subjects who are currently enrolled or planning to participate in a potentially confounding drug or device trial during the course of this study. Co-enrollment in concurrent trials is only allowed when document pre-approval is obtained from the Medtronic study manager.~12. Pregnant women or breastfeeding women, or women of child bearing potential and who are not on a reliable form of birth regulation method or abstinence.~13. Subjects with exclusion criteria required by local law (age or other).~14. Subjects with medical condition which precludes patient from participation in the opinion of the Investigator.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Micra Implant Group (Type: EXPERIMENTAL): Subjects with implant attempt with the Micra Transcatheter Pacing System (TPS)

Based on this trial design, predict the completion outcome and termination type (if applicable).